Recent Finacing
Recent Raise
Chimerix is a Durham, NC pharmaceutical company developing orally available broad-spectrum antiviral therapeutics, including clinical-stage CMX001 for severe viral infections/smallpox countermeasure and CMX157 for drug-resistant HIV.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors